Form D · Pharmaceuticals
Apellis Pharmaceuticals, Inc.
Crestwood, KY · CIK 0001492422
Offering snapshot reported Aug 17, 2017 · SEC filing
- Reported sold
- $20M Offering amount: $60.1M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 7, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2017 | Initial | $20,033,322 | No comparison | 16 | SEC filing |
| Feb 8, 2016 | Initial | $47,135,951 | No comparison | 7 | SEC filing |
| Jan 6, 2016 | Initial | $32,135,952 | No comparison | 6 | SEC filing |
| Jun 9, 2015 | Amendment | $17,732,150 | $11,732,150vs Dec 17, 2014 | 1 | SEC filing |
| Dec 17, 2014 | Initial | $6,000,000 | No comparison | 1 | SEC filing |
| Aug 27, 2014 | Amendment | $17,842,487 | $11,842,487vs Aug 5, 2013 | 25 | SEC filing |
| Aug 5, 2013 | Initial | $6,000,000 | No comparison | 1 | SEC filing |
| Jul 25, 2012 | Initial | $692,995 | No comparison | 9 | SEC filing |
| Jun 20, 2011 | Amendment | $2,967,500 | $1,279,000vs Jun 1, 2011 | 15 | SEC filing |
| Jun 1, 2011 | Initial | $1,688,500 | No comparison | 11 | SEC filing |
| May 21, 2010 | Initial | $1,700,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-293019
Source: Form D, filed Aug 17, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Adelman | Director |
| Steven Axon | Executive |
| Marie Claude Bernal | Director |
| Gerald Chan | Director |
| Bihua Chen | Director |
| David Darst | Director |
| David Darst, Jr. | Director |
| Pascal Deschatelets | Executive |
| A. Sinclair Dunlop | Director |
| Sinclair Dunlop | Director |
| Cedric Francois | Director, Executive |
| Daniel Geffken | Executive |
| Stephen Gillies | Director |
| Federico Grossi | Executive |
| Maha Katabi | Director |
| Robert Kim | Executive |
| Alec Machiels | Director |
| Stephanie O'brien | Director |
| Douglas Onsi | Director |
| Nicole Perry | Executive |
| David Watson | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6400 Westwind Way Suite A
Crestwood, KY, 40014
Crestwood, KY, 40014